<< Back To Authors

Overview

Benjamin Ryan

Editor-at-Large for POZ and its sister publications Hep, Cancer Health and Real Health, where he covers the science of HIV, hepatitis C and cancer. He has also written for The New York Times, The Guardian, New York, The Nation, The Atlantic, The Marshall Project, The Village Voice, The New York Observer, Men's Journal, City & State, Quartz, Out and The Advocate.

Articles

Winnie Byanyima, executive director of UNAIDS

Facing COVID-19 Headwinds, UNAIDS Calls for Stepped-Up HIV Effort

UNAIDS hopes nations will follow the lead of a number of sub-Saharan African countries that are gaining control of their HIV epidemics.

HIV Tied to Lower Prostate Cancer Risk

So concluded a pooled analysis of 27 studies mostly conducted in higher income nations.

Doctor-Patient Shared Decision-Making Can Help Guide PrEP Use Choices

At a recent conference, a leading infectious disease provider in New York City advocated this as a means of improving patient satisfaction.

Testing, Treating Hep C in Australian Gay and Bi Men With HIV Drives Down New Cases

Hepatitis C commonly spreads through condomless sex and injection drug use among men who have sex with men.

Viral Reservoir’s Production of HIV RNA Tied to Harmful Inflammation

The amount of virus hidden in reservoir cells was not tied to inflammation in a small study, but the cells’ production of new RNA was.

HIV-Related Death Rate Drops by Half in Seven Years

This impressive decline occurred across subgroups, whether the data were broken down by age, sex or race.

PrEP Referrals for Highest-Risk Groups Need Major Boost

A CDC-run study analyzed a program in which health departments screened for PrEP eligibility and wrote referrals.

NIAID HIV-infected H9 T cell Scanning electromicrograph of an HIV-infected H9 T cell.

HIV Treatment Doesn’t Eliminate Accelerated Cell Aging

People with untreated HIV in a recent study had signs of faster cell aging, which treatment reduced but did not eliminate.

Hot topics

Forums: Support and discussion

Blogs: The community speaks

POZ Stories: Get inspired

Magazine: Search the archives

HIV: The Basics

Recursos de VIH/SIDA en Español

AIDS Is Everyday

Ask POZ

HIV’s Ties to Policing, Incarceration

Incarceration and police discrimination are linked to HIV risk in Black gay and bisexual men.

Does Metformin Promote Weight Loss?

The diabetes drug was tied to a decline in body weight during a small study of people with HIV who didn’t have the condition.

Up-and-Coming Long-Acting Treatment

A new long-acting injectables HIV drug shows promise in monkey study.

Statin Study Looks Into Aging With HIV

The REPRIEVE study, which is primarily looking at a statin’s effect on cardiovascular disease, is shedding light on many other mysteries.

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

The company also has plans to study monthly islatravir’s efficacy as HIV prevention among men who have sex with men.

Bictegravir and Dolutegravir Tied to Metabolic Side Effects

These two integrase inhibitors are associated with high blood sugar and diabetes.

Providers Can Successfully Administer Monthly Injectable HIV Treatment

A study analyzed how well people with HIV and their health care providers can navigate the experimental long-acting injectable Cabenuva.

Overweight or fat adult man in very tight jeans on a gray background. Healthcare, medicine

Switching to Integrase Inhibitors Not Tied to Gain in “Bad Fat”

A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.